Synapse Open Synapse
Biology

TRex Bio prices $117M IPO to support immune drug work

BioPharma Dive · · 2 min read

Eli Lilly is the largest equity holder in TRex, which is developing drugs that treat immunological conditions by activating “Treg” cells.

Latest from BioPharma Dive